Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: November 2009
IMB Update on Pandemic A(H1N1)v vaccines (2)
01 November 2009 | Irish Medicines Board
The European Commission on the recommendation of the European Medicines Agency (EMEA) has granted licences for three vaccines against influenza A(H1N1)v for use in the EU. These vaccines are: Celvapan (Baxter), Focetria (Novartis), Pandemrix (GlaxoSmithKline).... Read more
Blopress
01 November 2009 | New Products
Company: Takeda UK Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Candesartan cilexetil 2mg, 4mg, 8mg, 16mg, 32mg. Description: 2mg: Round white tablets. 4mg: Round white tablets with a single score line on both sides. 8mg: Round pale pink... Read more
Blopress Plus
01 November 2009 | New Products
Company: Takeda UK Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredients: Candesartan cilexetil/hydrochlorothiazide 8mg/12.5mg, 16mg/12.5mg, 32mg/12.5mg, 32mg/25mg. Description: 8mg/12.5mg: White, oval tablets with a score with 8 C on both sides. 16mg/12.5mg: Light pink, oval tablets with a... Read more
Clopidogrel HCS
01 November 2009 | New Products
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Clopidogrel (as hydrochloride) 75mg. Description: Pink, round and slightly convex film-coated tablets. Presentation: 28, price on request. Indications: Prevention of atherothrombotic events in patients suffering from myocardial infarction... Read more
Instanyl
01 November 2009 | New Products
Company: Nycomed Products Ltd. Legal category: Controlled Drug. GMS. Sport Prohibited. Active ingredient: Fentanyl (as citrate) 50μg, 100μg, 200μg/dose nasal spray. Description: Nasal spray, solution. Presentation: For all strengths: 10, €91.70; 20, €183.40. Indications: Management of breakthrough pain in adult... Read more
Nplate
01 November 2009 | New Products
Company: Amgen Ireland. Legal category: Hospital only. Sport Pending. Active ingredient: Romiplostim 250μg, Description: Powder for solution for injection in vial. Presentation: Single pack containing one 250µg vial. Price available on request. Indications: Adult chronic immune (idiopathic) thrombocytopenic purpura (ITP)... Read more
Ondansetron
01 November 2009 | New Products
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Ondansetron (as hydrochloride dihydrate) 4mg, 8mg. Description: Yellow, oblong film coated tablet marked with strength on one side. 4mg plain on reverse; 8mg scoreline on reverse. The 8mg... Read more
Profal
01 November 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Finasteride 5mg Description: Blue, round, biconvex film-coated tablet marked F5. Presentation: 28, €20.66. Indications: Treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate... Read more
Victoza
01 November 2009 | New Products
Company: Novo Nordisk Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Liraglutide 6mg/ml. Description: Clear, colourless, isotonic solution for injection in pre-filled pen. Presentation: 2, €89.06. 3, €133.59 Indications: Type 2 diabetes mellitus in adults, to achieve glycaemic control.... Read more
Denzapine tablets (50mg & 200mg) & Denzapine 50mg/ml Oral Suspension
01 November 2009 | New Presentations
Company: Merz Pharma UK Ltd. Legal category: Prescription. Sport Permitted. Active ingredient: Clozapine 50mg, 200mg, 50mg/ml. Description: 50mg: Round, flat yellow, bevel edged tablets embossed with 50 over a pressure sensitive breakline on one face. 200mg: Large, oval-shaped yellow tablets... Read more
Monotrim 100mg & 200mg
01 November 2009 | New Presentations
Company: Chemidex Pharma Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Trimethoprim, 100mg, 200mg. Description: White, round tablets with a single score line with respectively AE and 2 or DE and 5 on each side of the score line.... Read more
Salofalk Rectal Foam
01 November 2009 | New Presentations
Company: Dr Falk Pharma UK Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Mesalazine 1g per actuation. Description: Rectal foam. Presentation: 14 actuations with 14 PVC applicators, €37.24. Indication: Treatment of active, mild ulcerative colitis of the sigmoid colon... Read more
Estraderm TTS Discontinued
01 November 2009 | Discontinued Products
Novartis Ireland Ltd wish to announce the discontinuation of Estraderm TTS 100mcg patches pack size 8, from January 2010 due to cessation of production at the registered manufacturing site. Please also note that as of May 2010, Estraderm TTS 25mcg... Read more
Trinordiol Discontinued
01 November 2009 | Discontinued Products
Wyeth Pharmaceuticals Ltd. would like to inform you of their intention to discontinue the marketing of Trinordiol tablets. Trinordiol tablets will be discontinued when current stock is exhausted. Wyeth regrets any inconvenience this discontinuation may cause. Please do not hesitate... Read more
Xylocaine 4% w/v Topical Mucosal Solution in Short Supply
01 November 2009 | Discontinued Products
AstraZeneca regrets to inform you that due to a recent manufacturing issue, supplies of Xylocaine 4% w/v Topical Mucosal Solution will be in short supply over the coming weeks and are likely to be fully depleted within 5 to 6... Read more
